Search

everythinglearnresearchcommunity

for

Search:↓

Black patients are underrepresented in alopecia research, highlighting the need for more inclusive studies.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Injections with 0.5% minoxidil effectively treat female hair loss, increasing hair density and thickness.

Women treated with X-ray for scalp fungus as children had a higher chance of hair loss, especially with higher radiation doses and severe fungus infections.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

64 drugs can cause hair loss, needing better monitoring and updated labels.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

Current treatments for alopecia show no significant long-term benefits.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

People with Alopecia Areata have a higher risk of heart-related health issues.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.